Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Samuel Ejadi | Researchclopedia

Back to researchers

Samuel Ejadi

University of California, Irvine

46

Works

3,377

Citations

18

h-index

25

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Prostate Cancer Treatment and Research Immunotherapy and Immune Responses

Affiliations

Translational Genomics Research Institute2014–2016

Memorial Sloan Kettering Cancer Center2006–2008

Johns Hopkins University2000–2000

Thomas Jefferson University2000–2000

University of California, Irvine2019–2022

Top Works

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong,Yoon‐Koo Kang,et al.

2020867 citations

Colorectal Cancer Treatments and Studies

CAR-T cell therapy research

Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study

Chiun Hsu,Se‐Hoon Lee,et al.

2017466 citations

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study

Aaron R. Hansen,Christophe Massard,et al.

2018367 citations

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

Bert H. O’Neil,John M. Wallmark,et al.

2017303 citations

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal

Patrick A. Ott,Sarina A. Piha‐Paul,et al.

2017250 citations

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

Amita Patnaik,Leonard J. Appleman,et al.

2016233 citations

Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape

Aleksandar Sekulić,Paul Haluska,et al.

2008148 citations

Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with previously treated, recurrent or refractory ovarian cancer: A phase Ib, open-label expansion trial.

Mary L. Disis,Manish R. Patel,et al.

2015108 citations

Mapping the binding site of aflatoxin B1 in DNA: systematic analysis of the reactivity of aflatoxin B1 with guanines in different DNA sequences

Matt Benasutti,Samuel Ejadi,et al.

1988104 citations